Ebastine and Buprenorphine: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Buprenorphine
Ebastine
No brand names on record
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Both buprenorphine (a pain and addiction medicine) and ebastine (an antihistamine) can affect the timing of your heartbeat. Doctors call this QT prolongation. When two medicines that both do this are taken together, the effect can add up and, in rare cases, lead to an irregular heartbeat.
The good news is that this concern is mostly theoretical for these two drugs, meaning it hasn't been clearly seen in studies, just predicted. Your risk is higher if you have things like low potassium or magnesium, a slow heart rate, or a known heart rhythm problem. Please don't stop either medicine on your own. Just let your pharmacist or doctor know you take both so they can keep you safe.
Effect: Additive QT-interval prolongation with concurrent buprenorphine and ebastine. Both agents are independently associated with QT effects; combining them may increase torsadogenic risk. Neither is a relevant prodrug here, so this is a straightforward pharmacodynamic (additive) interaction, not a metabolic one.
Evidence: Theoretical; magnitude and onset unspecified. Rated major on file.
Management:
- Avoid concomitant use where feasible.
- Assess and correct modifiable risk factors: hypokalemia, hypomagnesemia, bradycardia, CHF, baseline QTc prolongation, congenital long-QT, digitalis therapy, recent cardioversion.
- Consider ECG and electrolyte monitoring if co-prescribed.
What happens
An increased risk of QT interval prolongation
Interaction Deep Dive
Refrain from using buprenorphine together with agents capable of prolonging the QT interval342. It remains unknown what risk arises when buprenorphine is paired with other QT-prolonging drugs. When prescribing buprenorphine to patients who have risk factors, including hypokalemia, bradycardia, recent conversion from atrial fibrillation, congestive heart failure, digitalis therapy, baseline QT prolongation, subclinical long-QT syndrome, or severe hypomagnesemia, take these observations into account during clinical decision-making1.
Why it happens (mechanism)
Additive QT interval prolongation
How to manage this interaction
Here is how a care team typically handles this combination:
- They may avoid using both together when there is a suitable alternative, or watch you more closely if both are needed.
- They may check your potassium and magnesium levels and correct any that are low, since low levels raise the risk.
- They may order an ECG (heart tracing) if you have heart risk factors.
What you should do: Keep taking both exactly as prescribed unless your prescriber tells you otherwise. Tell your pharmacist and doctor you take both, and mention any history of heart rhythm problems, fainting, or palpitations.
Management is individual — confirm any change with your pharmacist or prescriber.
Common questions
Can I take Ebastine and Buprenorphine together?
Buprenorphine and ebastine can both stretch the QT interval, so combining them may add up and, in theory, raise the risk of an abnormal heart rhythm. Let your care team know you take both so they can decide whether to avoid the combo or monitor you more closely. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Ebastine and Buprenorphine interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Ebastine and Buprenorphine interaction managed?
Here is how a care team typically handles this combination: They may avoid using both together when there is a suitable alternative, or watch you more closely if both are needed. They may check your potassium and magnesium levels and correct any that are low, since low levels raise the risk. They may order an ECG (heart tracing) if you have heart risk factors. What you should do: Keep taking both… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
Questions for your pharmacist
- Does my dose of Ebastine or Buprenorphine need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (4)
- Product Information: BRIXADI(TM) subcutaneous extended-release injection, buprenorphine subcutaneous extended-release injection. Braeburn Inc (per FDA), Plymouth Meeting, PA, 2023. DailyMed
- Product Information: BUTRANS(R) transdermal system patch, buprenorphine transdermal system patch. Purdue Pharma L.P. (per FDA), Stamford, CT, 2016. DailyMed
- Product Information: BELBUCA(TM) buccal film, buprenorphine buccal film. Endo Pharmaceuticals Inc. (per FDA), Malvern, PA, 2016.
- Product Information: BUPRENEX(R) intravenous injection, intramuscular injection, buprenorphine HCl intravenous injection, intramuscular injection. Indivior Inc. (per DailyMed), Richmond, VA, 2016. DailyMed
Keep reading about Buprenorphine
Keep reading about Ebastine
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist